Literature DB >> 21723619

How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires.

Jaime Delgadillo1, Scott Payne, Simon Gilbody, Christine Godfrey, Stuart Gore, Dawn Jessop, Veronica Dale.   

Abstract

BACKGROUND: Depression is highly comorbid with alcohol and drug problems, resulting in greater impairment, reduced treatment adherence and poor outcomes. Little evidence exists to support the use of mental health screening tools in routine addiction treatment. This study tested the validity and reliability of PHQ-9 and PHQ-2 as depression case finding tools in an outpatient drug treatment sample in the United Kingdom.
METHODS: A sample of 103 patients took part in diagnostic assessments using CIS-R and completed brief screening questionnaires. A subgroup of 60 patients completed retests after 4 weeks. Diagnostic results were compared to brief measures using receiver operating characteristic (ROC) curves. Psychometric properties were also calculated to evaluate the validity and reliability of self-completed questionnaires.
RESULTS: A PHQ-9 score ≥ 12 had a sensitivity of 81% and specificity of 75% for major depression, also displaying good retest reliability (intra-class correlation, 0.78) and internal consistency (Cronbach's alpha, 0.84). PHQ-2 had 68% sensitivity and 70% specificity, with more modest retest reliability (0.66) and internal consistency (0.64). LIMITATIONS: Diagnostic interviews did not consider the temporal sequencing of the onset of drug use and mental health problems.
CONCLUSIONS: PHQ-9 is a valid and reliable depression screening tool for drug and alcohol users. The brevity and ease of administration of self-completed questionnaires make them useful clinical tools in addiction services commonly encountering a high prevalence of depression.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21723619     DOI: 10.1016/j.jad.2011.06.017

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  Identifying Depression in a National Sample of Caregivers Investigated in Regard to Their Child's Welfare.

Authors:  Emmeline Chuang; Rebecca Wells; Gregory A Aarons
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

2.  The Validity of the Montgomery-Asberg Depression Rating Scale in an Inpatient Sample with Alcohol Dependence.

Authors:  Breanne Hobden; Melanie L Schwandt; Mariko Carey; Mary R Lee; Mehdi Farokhnia; Sofia Bouhlal; Christopher Oldmeadow; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2017-05-22       Impact factor: 3.455

3.  Prevalence and Predictors of Symptoms of Depression Among Individuals Seeking Treatment from Australian Drug and Alcohol Outpatient Clinics.

Authors:  Breanne Hobden; Mariko Carey; Jamie Bryant; Rob Sanson-Fisher; Christopher Oldmeadow
Journal:  Community Ment Health J       Date:  2019-09-12

4.  Perceived need for depression treatment among persons entering inpatient opioid detoxification.

Authors:  Michael D Stein; Olga J Santiago Rivera; Bradley J Anderson; Genie L Bailey
Journal:  Am J Addict       Date:  2017-04-28

5.  Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids).

Authors:  D Shmulewitz; M Stohl; E Greenstein; S Roncone; C Walsh; E Aharonovich; M M Wall; D S Hasin
Journal:  Psychol Med       Date:  2021-11-01       Impact factor: 10.592

6.  Validation of brief screening measures for depression and anxiety in young people with substance use disorders.

Authors:  Kate H Bentley; Hitoshi Sakurai; Kelsey L Lowman; Lisa Rines-Toth; James McKowen; Paola Pedrelli; A Eden Evins; Amy M Yule
Journal:  J Affect Disord       Date:  2021-01-07       Impact factor: 4.839

7.  Cannabis use as a moderator of cognitive behavioral therapy for insomnia.

Authors:  Mary Beth Miller; Ryan W Carpenter; Lindsey K Freeman; Ashley F Curtis; Ali M Yurasek; Christina S McCrae
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

8.  Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM-5.

Authors:  Zachary L Mannes; Dvora Shmulewitz; Ofir Livne; Malki Stohl; Deborah S Hasin
Journal:  Alcohol Clin Exp Res       Date:  2021-09-28       Impact factor: 3.928

9.  Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use.

Authors:  Dvora Shmulewitz; Eliana Greenstein; Malka Stohl; David S Fink; Stephanie Roncone; Claire Walsh; Efrat Aharonovich; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2022-03-17       Impact factor: 4.852

10.  Disentangling psychopathology, substance use and dependence: a factor analysis.

Authors:  Jaime Delgadillo; Jan R Böhnke; Elizabeth Hughes; Simon Gilbody
Journal:  BMC Psychiatry       Date:  2016-08-08       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.